FebriDx® is a rapid point-of-care test that uses a fingerstick blood sample to aid in the differentiation between bacterial infection and non-bacterial etiology. It measures two key host-response biomarkers: CRP, an indicator of systemic inflammation, and MxA, a marker specific to acute viral infection. Together, these biomarkers provide clear, actionable insight to support timely and confident respiratory infection decision-making.